Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014.

Ringshausen FC, Wagner D, de Roux A, Diel R, Hohmann D, Hickstein L, Welte T, Rademacher J.

Emerg Infect Dis. 2016 Jun;22(6):1102-5. doi: 10.3201/eid2206.151642.

2.

[New and Current Concepts of Therapy in Non-CF Bronchiectasis].

Allewelt M, de Roux A.

Dtsch Med Wochenschr. 2016 May;141(10):694-9. doi: 10.1055/s-0042-104742. Epub 2016 May 13. Review. German.

PMID:
27176062
3.

[Management of Adult Community-acquired Pneumonia and Prevention - Update 2016].

Ewig S, Höffken G, Kern WV, Rohde G, Flick H, Krause R, Ott S, Bauer T, Dalhoff K, Gatermann S, Kolditz M, Krüger S, Lorenz J, Pletz M, de Roux A, Schaaf B, Schaberg T, Schütte H, Welte T.

Pneumologie. 2016 Mar;70(3):151-200. doi: 10.1055/s-0042-101873. Epub 2016 Feb 29. German.

PMID:
26926396
4.

Bronchiectasis in Germany: a population-based estimation of disease prevalence.

Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J.

Eur Respir J. 2015 Dec;46(6):1805-7. doi: 10.1183/13993003.00954-2015. Epub 2015 Aug 20. No abstract available.

5.

[PROGNOSIS - The PROspective German NOn-CF BronchiectaSIS Patient Registry].

Rademacher J, de Roux A, Ringshausen FC.

Pneumologie. 2015 Jul;69(7):391-3. doi: 10.1055/s-0034-1392254. Epub 2015 Jul 14. German.

6.

Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends.

Ringshausen FC, de Roux A, Pletz MW, Hämäläinen N, Welte T, Rademacher J.

PLoS One. 2013 Aug 1;8(8):e71109. doi: 10.1371/journal.pone.0071109. Print 2013.

7.

Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011.

Ringshausen FC, Apel RM, Bange FC, de Roux A, Pletz MW, Rademacher J, Suhling H, Wagner D, Welte T.

BMC Infect Dis. 2013 May 21;13:231. doi: 10.1186/1471-2334-13-231.

8.

Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1 ×, 2 ×, or 4 ×) in healthy subjects aged 70 years or older.

Lode H, Schmoele-Thoma B, Gruber W, Ahlers N, Fernsten P, Baker S, Razmpour A, Siber G, Hackell J, Lockhart S, Burkhardt O, Welte T, de Roux A.

Vaccine. 2011 Jul 12;29(31):4940-6. doi: 10.1016/j.vaccine.2011.04.132. Epub 2011 May 17.

PMID:
21596077
9.

Mobile Air Quality Studies (MAQS)-an international project.

Groneberg DA, Scutaru C, Lauks M, Takemura M, Fischer TC, Kölzow S, van Mark A, Uibel S, Wagner U, Vitzthum K, Beck F, Mache S, Kreiter C, Kusma B, Friedebold A, Zell H, Gerber A, Bock J, Al-Mutawakl K, Donat J, Geier MV, Pilzner C, Welker P, Joachim R, Bias H, Götting M, Sakr M, Addicks JP, Börger JA, Jensen AM, Grajewski S, Shami A, Neye N, Kröger S, Hoffmann S, Kloss L, Mayer S, Puk C, Henkel U, Rospino R, Schilling U, Krieger E, Westphal G, Meyer-Falcke A, Hupperts H, de Roux A, Tropp S, Weiland M, Mühlbach J, Steinberg J, Szerwinski A, Falahkohan S, Sudik C, Bircks A, Noga O, Dickgreber N, Dinh QT, Golpon H, Kloft B, Groneberg RN, Witt C, Wicker S, Zhang L, Springer J, Kütting B, Mingomataj EC, Fischer A, Schöffel N, Unger V, Quarcoo D.

J Occup Med Toxicol. 2010 Apr 9;5:8. doi: 10.1186/1745-6673-5-8.

10.

[Intermittent hypoxic training--the state of science].

Schöffel N, Senff T, Gerber A, de Roux A, Bauer TT, Groneberg DA.

Pneumologie. 2008 May;62(5):279-83. doi: 10.1055/s-2008-1038113. Review. German.

PMID:
18484547
11.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM.

Clin Infect Dis. 2008 Apr 1;46(7):1015-23. doi: 10.1086/529142. Erratum in: Clin Infect Dis. 2008 May 1;46(9):1488. Schmöele-Thoma, B [corrected to Schmöle-Thoma, B].

PMID:
18444818
12.

A prediction model for bacterial etiology in acute exacerbations of COPD.

Lode H, Allewelt M, Balk S, De Roux A, Mauch H, Niederman M, Schmidt-Ioanas M.

Infection. 2007 Jun;35(3):143-9.

PMID:
17565454
13.

Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia.

de Roux A, Cavalcanti M, Marcos MA, Garcia E, Ewig S, Mensa J, Torres A.

Chest. 2006 May;129(5):1219-25.

PMID:
16685012
14.

Mixed community-acquired pneumonia in hospitalised patients.

de Roux A, Ewig S, García E, Marcos MA, Mensa J, Lode H, Torres A.

Eur Respir J. 2006 Apr;27(4):795-800.

15.

[Serologic early diagnosis of pneumonia caused by Mycoplasma pneumoniae].

Schmidt-Ioanas M, Bender M, Roth A, Allewelt M, de Roux A, Lode H.

Dtsch Med Wochenschr. 2006 Mar 24;131(12):613-7. German.

PMID:
16544236
16.

Pneumococcal vaccination.

de Roux A, Lode H.

Eur Respir J. 2005 Dec;26(6):982-3. No abstract available.

17.

Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients.

de Roux A, Marx A, Burkhardt O, Schweiger B, Borkowski A, Banzhoff A, Pletz MW, Lode H.

Vaccine. 2006 Mar 6;24(10):1537-42. Epub 2005 Oct 19.

PMID:
16288937
18.

Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines.

Schmidt-Ioanas M, Pletz MW, de Roux A, Lode H.

Respir Med. 2006 Apr;100(4):639-47. Epub 2005 Sep 29.

19.

New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.

Schmidt-Ioanas M, de Roux A, Lode H.

Curr Opin Crit Care. 2005 Oct;11(5):481-6. Review.

PMID:
16175036
20.

[Pneumococcal vaccination in obstructive lung diseases -- what can we expect?].

Rose M, Lode H, de Roux A, Zielen S.

Dtsch Med Wochenschr. 2005 Mar 4;130(9):461-5. Review. German.

PMID:
15731959
21.

Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids.

de Roux A, Schmidt N, Rose M, Zielen S, Pletz M, Lode H.

Respir Med. 2004 Dec;98(12):1187-94.

22.

Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.

Pletz MW, Rau M, Bulitta J, De Roux A, Burkhardt O, Kruse G, Kurowski M, Nord CE, Lode H.

Antimicrob Agents Chemother. 2004 Oct;48(10):3765-72.

23.

Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system.

García-Vázquez E, Marcos MA, Mensa J, de Roux A, Puig J, Font C, Francisco G, Torres A.

Arch Intern Med. 2004 Sep 13;164(16):1807-11.

PMID:
15364677
24.

Validation of predictive rules and indices of severity for community acquired pneumonia.

Ewig S, de Roux A, Bauer T, García E, Mensa J, Niederman M, Torres A.

Thorax. 2004 May;59(5):421-7.

25.

Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD.

Pletz MW, Ioanas M, de Roux A, Burkhardt O, Lode H.

Eur Respir J. 2004 Apr;23(4):532-7.

26.

Viral community-acquired pneumonia in nonimmunocompromised adults.

de Roux A, Marcos MA, Garcia E, Mensa J, Ewig S, Lode H, Torres A.

Chest. 2004 Apr;125(4):1343-51.

PMID:
15078744
27.

Recent developments in antibiotic treatment.

de Roux A, Lode H.

Infect Dis Clin North Am. 2003 Dec;17(4):739-51. Review.

PMID:
15008596
28.

Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.

Pletz MW, De Roux A, Roth A, Neumann KH, Mauch H, Lode H.

Antimicrob Agents Chemother. 2004 Mar;48(3):780-2.

29.

C-reactive protein levels in community-acquired pneumonia.

García Vázquez E, Martínez JA, Mensa J, Sánchez F, Marcos MA, de Roux A, Torres A.

Eur Respir J. 2003 Apr;21(4):702-5.

30.

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults.

Marcos MA, Jiménez de Anta MT, de la Bellacasa JP, González J, Martínez E, García E, Mensa J, de Roux A, Torres A.

Eur Respir J. 2003 Feb;21(2):209-14.

31.

Factors associated with unknown aetiology in patients with community-acquired pneumonia.

Ewig S, Torres A, Angeles Marcos M, Angrill J, Rañó A, de Roux A, Mensa J, Martínez JA, de la Bellacasa JP, Bauer T.

Eur Respir J. 2002 Nov;20(5):1254-62.

32.

[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].

Grysczyk H, De Roux A, Grassot A, Mauch H, Lode H.

Dtsch Med Wochenschr. 2002 Mar 8;127(10):492-6. German.

PMID:
11884987
33.

[Therapy of fungal infections of the lung].

de Roux A.

Dtsch Med Wochenschr. 2000 Feb 25;125(8):226. German. No abstract available.

PMID:
10723460

Supplemental Content

Loading ...
Support Center